Clinical Trials Directory

Trials / Completed

CompletedNCT04166578

Analgetic Effect of Two Solutions of Intracameral Anesthesia During Cataract Surgery in Patients

Comparison of Analgetic Effect of Two Solutions of Intracameral Anesthesia During Cataract Surgery: a Pilot Study

Status
Completed
Phase
Study type
Observational
Enrollment
62 (actual)
Sponsor
Medical University of Lublin · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Purpose: The aim of the study was to compare the analgetic effect of two solutions of intracameral anesthesia in patients undergoing cataract surgery and assess the factors influencing the patients' postoperative activities. Methods: In this prospective, single-blind, randomized study, a group of 62 patients undergoing cataract surgery received Mydrane (Mydrane group) or a combination of 1% solution of lignocaine and 0.025% solution of adrenalin (reference group) as an intraocular anesthetic. The analgetic effect of these two anesthetic methods was evaluated using psychological tools - Visual Analog Scale for Pain (VAS Pain) and Brief Pain Inventory-short form (BPI) on the next day after the surgery.

Conditions

Interventions

TypeNameDescription
DRUGlignocaineThe group of 62 patients undergoing cataract surgery received Mydrane (Mydrane group) or a combination of 1% solution of lignocaine and 0.025% solution of adrenalin (reference group) as an intraocular anesthetic
PROCEDUREPhacoemulsyficationPhacoemulsification is a technic of cataract surgery in which the eye's internal lens is emulsified with an ultrasonic handpiece and aspirated from the eye.
PROCEDUREIntraocular lens implantationAn intraocular lens implant is a synthetic, artificial lens placed inside the eye that replaces the focusing power of a natural lens that is surgically removed, usually as part of cataract surgery.
BEHAVIORALVisual Analog Scale for PainVAS for Pain is a new tool developed to assess the pain in quantitative terms.
BEHAVIORALBrief Pain Inventory-short formBPI short form is a tool developed to assess the pain in quantitative terms. The BPI allows patients to rate the severity of the pain and the grade to which their pain interferes with common dimensions of feeling and function.
DIAGNOSTIC_TESTBest corrected visual acuity measurmentMeasurement of the best vision correction that can be achieved, such as glasses, as measured on the standard Snellen eye chart. For example, if your uncorrected eyesight is 20/200, but you can see 20/20 with glasses, your BCVA is 20/20.
DIAGNOSTIC_TESTSlit-lamp biomicroscopySlit-lamp biomicroscopy allows study of ocular structures and their relationships.

Timeline

Start date
2017-01-01
Primary completion
2017-06-30
Completion
2017-07-31
First posted
2019-11-18
Last updated
2019-11-18

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT04166578. Inclusion in this directory is not an endorsement.